Future growth expectations in earnings/operating earnings/profits/EPS?

Aimco Pesticides targets around 20% annual growth by expanding current capacity and introducing two new niche, high-margin molecules within 3-5 years. New molecules focus on export markets and are expected to contribute significantly to sales and margins. Current EBITDA margins are improving, with expectations to reach double-digit operating margins soon, once price stabilization occurs. Contract manufacturing expansion planned, with CAPEX of ~₹10 crore, expected to add ₹100-150 crore turnover per year from increased capacity. Margins expected to improve from Q3 onwards as cost pass-through me

Any current/future new fundraising through debt or equity?

The company plans to fund its current expansion entirely through internal accruals, with no intention for further borrowing as per the discussion with Milan Shah. Current total debt stands at about ₹7 crore, with a plan to significantly reduce it by March. No mention or indication of any future equity fundraising in the transcript. The focus remains on reducing existing debt and utilizing internal funds for growth and capacity expansion.

Any current/future capex/capital investment/strategic investment?

Aimco Pesticides is planning a capacity expansion with an estimated CAPEX of around ₹10 crore. This expansion includes manufacturing capacity as well as utility improvements. The new capacity is expected to boost production from the current 350 tons per month to 500 tons per month by June or July next year. Post this expansion, the company anticipates an annual turnover increase of approximately ₹100-150 crore. Beyond the current expansion, there is a plan for one more expansion to produce a new molecule. For growth beyond these, the company will need to consider setting up a new manufacturing

Future growth expectations in sales/revenue/volumes?

Aimco Pesticides plans to grow about 20% annually by increasing current capacity with existing products and adding new molecules in the next 3-5 years. Two new niche molecules with high margin potential are being registered and expected to commercialize in 3-5 years. Expansion underway to increase production capacity from ~350 tons/month to 500 tons/month by June-July next year, which should add ₹100-150 crore turnover annually. Contract manufacturing business is stabilizing around ₹22-23 crore per quarter with plans to increase volumes via capacity expansion. Export sales currently ~50% of tu

Current/ Expected Orderbook/ Pending Orders?

Current order book volume supports a quarterly revenue run rate of around ₹80 crores, aiming for an annual turnover close to ₹350 crores. Contract manufacturing sales have ramped up significantly, contributing about ₹20 crores in Q2, expected to stabilize at ₹22-23 crores per quarter onwards. Discussions are ongoing to increase contract manufacturing quantities, with capacity expansion work starting in December and expected to complete by June/July next year. New molecule registrations are in progress, with expectations of receiving at least one product registration this financial year,

IN US

Sale is live|00:00:00left today

Aimco Pesticides LtdQ3 FY21Fertilizers & Agrochemicals

Aimco Pesticides Ltd Q3 FY21 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹56.6Market Cap: ₹57 CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 1

Fundraise

Order

Yes

Capex

Yes

3 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 2

→Aimco Pesticides plans to grow about 20% annually by increasing current capacity with existing products and adding new molecules in the next 3-5 years.
→Two new niche molecules with high margin potential are being registered and expected to commercialize in 3-5 years.
→Expansion underway to increase production capacity from ~350 tons/month to 500 tons/month by June-July next year, which should add ₹100-150 crore turnover annually.
→Contract manufacturing business is stabilizing around ₹22-23 crore per quarter with plans to increase volumes via capacity expansion.
→Export sales currently ~50% of turnover, expected to grow further with new molecules focused more on exports.
→Branded formulation business will be grown cautiously and without aggressive expansion.
→Overall, confident of steady sales with seasonal variation and expectation of improved profitability from Q3 onwards.

Margin guidance

Category 1

→Aimco Pesticides targets around 20% annual growth by expanding current capacity and introducing two new niche, high-margin molecules within 3-5 years.
→New molecules focus on export markets and are expected to contribute significantly to sales and margins.
→Current EBITDA margins are improving, with expectations to reach double-digit operating margins soon, once price stabilization occurs.
→Contract manufacturing expansion planned, with CAPEX of ~₹10 crore, expected to add ₹100-150 crore turnover per year from increased capacity.
→Margins expected to improve from Q3 onwards as cost pass-through mechanisms mature.
→Cautious growth in B2C branded formulation segment; main focus remains on B2B manufacturing with higher margins.
→Debt reduction underway, which should positively impact profitability.
→Overall, the company expects more stable and higher profitability, driven by capacity ramp-up, new products, and better pricing power.

3 more insights locked — sign up free to unlock

Fundraise plans

→The company plans to fund its current expansion entirely through internal accruals, with no intention for further borrowing as per the discussion with Milan Shah.
→Current total debt stands at about ₹7 crore, with a plan to significantly reduce it by March.
→No mention or indication of any future equity fundraising in the transcript.
→The focus remains on reducing existing debt and utilizing internal funds for growth and capacity expansion.

Order book

Yes

→Current order book volume supports a quarterly revenue run rate of around ₹80 crores, aiming for an annual turnover close to ₹350 crores.
→Contract manufacturing sales have ramped up significantly, contributing about ₹20 crores in Q2, expected to stabilize at ₹22-23 crores per quarter onwards.
→Discussions are ongoing to increase contract manufacturing quantities, with capacity expansion work starting in December and expected to complete by June/July next year.
→New molecule registrations are in progress, with expectations of receiving at least one product registration this financial year, although no concrete updates yet.
→Expansion plans include adding capacity to increase production from the current 350 tons/month to 500 tons/month by June/July next year, supporting higher order fulfillment.
→The company is confident of maintaining and increasing sales volumes, contingent on external factors like monsoon and global conditions.

Capex plans

Yes

→Aimco Pesticides is planning a capacity expansion with an estimated CAPEX of around ₹10 crore.
→This expansion includes manufacturing capacity as well as utility improvements.
→The new capacity is expected to boost production from the current 350 tons per month to 500 tons per month by June or July next year.
→Post this expansion, the company anticipates an annual turnover increase of approximately ₹100-150 crore.
→Beyond the current expansion, there is a plan for one more expansion to produce a new molecule.
→For growth beyond these, the company will need to consider setting up a new manufacturing site, anticipated around two to two and a half years from now.
→The expansion will be funded through internal accruals without any additional borrowings.

How does Aimco Pesticides Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

1Aimco Pesticides Ltd

Rev 2Mar 1

See full Fertilizers & Agrochemicals sector rankings

Want more stocks like Aimco Pesticides Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio